Gunnar Sæther • 1972 • Trondheim • 8 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
B BIO PHARMA NORWAY AS	Managing Director/CEO	1,558,436	1,769,300	25 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
F FORTUNA EUROPE AS	Board Member	763,388	-116,154	25 % indirectly
C CECILIE LØVØS VEG 2 AS	Contact Person	344,528	1,443,980	25 % indirectly
B BIO PHARMA NORWAY AS	Board Member	1,558,436	1,769,300	25 % indirectly
G GUTS HOLDING AS	Contact Person	-	-1,838,441	25 % directly
N NORDIC PRINT AS	Chairman	15,205,584	476,970	25 % indirectly

Last update: Apr 13, 2023

Related industries4

Administrative and support service activities
Real estate activities
Wholesale and retail trade; repair of motor vehicles and motorcycles
Manufacturing

Direct relationships5

TS
Terje Sæther1975
CECILIE LØVØS VEG 2 AS, BIO PHARMA NORWAY AS, GUTS HOLDING AS, NORDIC PRINT AS
SS
Siri Nielsen Sæther1968
CECILIE LØVØS VEG 2 AS, BIO PHARMA NORWAY AS, GUTS HOLDING AS
OL
Odd-Arne Landevåg1956
FORTUNA EUROPE AS
TB
Tom Benestad1971
BIO PHARMA NORWAY AS
IF
Ivar Larsen Fjeldberg1953
FORTUNA EUROPE AS

Shares owned by Gunnar Sæther

Name	Share class	Total operating income	Total equity	Share
G GUTS HOLDING AS	Ordinære aksjer	0	-1,838,441	25 % directly
F FORTUNA EUROPE AS		763,388	-116,154	25 % indirectly
C CECILIE LØVØS VEG 2 AS		344,528	1,443,980	25 % indirectly
B BIO PHARMA NORWAY AS		1,558,436	1,769,300	25 % indirectly
N NORDIC PRINT AS		15,205,584	476,970	25 % indirectly
M MEDICIAL AS		656,125	85,522	3.13 % indirectly
B BLOCKCHAIN TECHNOLOGY AS		0	1,592,288	2.78 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024